Bank of Montreal’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$495M Buy
3,549,224
+80,430
+2% +$11.3M 0.18% 97
2025
Q4
$426M Buy
3,468,794
+385,555
+13% +$46.9M 0.15% 110
2025
Q3
$342M Buy
3,083,239
+175,212
+6% +$19.9M 0.13% 127
2025
Q2
$322M Sell
2,908,027
-362,283
-11% -$38.6M 0.15% 118
2025
Q1
$366M Sell
3,270,310
-31,347
-0.9% -$3.23M 0.18% 103
2024
Q4
$305M Sell
3,301,657
-75,415
-2% -$6.79M 0.14% 124
2024
Q3
$282M Sell
3,377,072
-970,680
-22% -$74.1M 0.12% 135
2024
Q2
$370M Buy
4,347,752
+753,545
+21% +$50.3M 0.11% 111
2024
Q1
$306M Sell
3,594,207
-1,077,840
-23% -$82.9M 0.09% 127
2023
Q4
$397M Buy
4,672,047
+1,907,119
+69% +$148M 0.12% 101
2023
Q3
$235M Buy
2,764,928
+293,746
+12% +$22.6M 0.08% 138
2023
Q2
$210M Buy
2,471,182
+596,787
+32% +$47.6M 0.07% 143
2023
Q1
$159M Sell
1,874,395
-373,628
-17% -$30.9M 0.06% 170
2022
Q4
$193M Buy
2,248,023
+558,176
+33% +$44.2M 0.08% 146
2022
Q3
$144K Sell
1,689,847
-779,075
-32% -$49.1M 0.06% 172
2022
Q2
$210K Sell
2,468,922
-546,664
-18% -$33.8M 0.1% 143
2022
Q1
$256M Sell
3,015,586
-1,332,656
-31% -$85.2M 0.12% 134
2021
Q4
$370M Buy
4,348,242
+924,201
+27% +$63.7M 0.2% 101
2021
Q3
$291M Sell
3,424,041
-359,947
-10% -$25.3M 0.13% 134
2021
Q2
$322M Buy
3,783,988
+1,239,453
+49% +$82.8M 0.16% 114
2021
Q1
$165M Sell
2,544,535
-444,722
-15% -$28.7M 0.11% 166
2020
Q4
$187M Buy
2,989,257
+389,992
+15% +$23.5M 0.12% 143
2020
Q3
$163M Buy
2,599,265
+13,612
+0.5% +$944K 0.14% 136
2020
Q2
$193M Buy
2,585,653
+300,064
+13% +$23M 0.18% 111
2020
Q1
$176M Sell
2,285,589
-405,429
-15% -$28M 0.2% 102
2019
Q4
$175M Buy
2,691,018
+378,230
+16% +$24.6M 0.13% 142
2019
Q3
$147M Sell
2,312,788
-33,701
-1% -$2.2M 0.13% 145
2019
Q2
$159M Buy
2,346,489
+174,780
+8% +$11.5M 0.13% 137
2019
Q1
$141M Sell
2,171,709
-75,002
-3% -$4.99M 0.12% 153
2018
Q4
$141M Sell
2,246,711
-27,500
-1% -$1.92M 0.13% 146
2018
Q3
$176M Sell
2,274,211
-282,225
-11% -$21.3M 0.14% 148
2018
Q2
$181M Sell
2,556,436
-784,866
-23% -$55.4M 0.15% 136
2018
Q1
$252M Buy
3,341,302
+781,312
+31% +$62.1M 0.22% 91
2017
Q4
$183M Buy
2,559,990
+479,647
+23% +$36.4M 0.16% 132
2017
Q3
$169M Sell
2,080,343
-994,238
-32% -$76M 0.15% 135
2017
Q2
$218M Buy
3,074,581
+548,128
+22% +$36.5M 0.21% 97
2017
Q1
$172M Buy
2,526,453
+324,187
+15% +$22.8M 0.16% 126
2016
Q4
$162M Buy
2,202,266
+326,745
+17% +$24.3M 0.17% 119
2016
Q3
$148M Sell
1,875,521
-3,252,149
-63% -$264M 0.16% 122
2016
Q2
$428M Buy
5,127,670
+945,744
+23% +$83.9M 0.49% 38
2016
Q1
$384M Sell
4,181,926
-498,837
-11% -$45M 0.41% 44
2015
Q4
$474M Sell
4,680,763
-566,070
-11% -$58.9M 0.57% 30
2015
Q3
$515M Buy
5,246,833
+324,626
+7% +$36.1M 0.71% 24
2015
Q2
$576M Sell
4,922,207
-42,219
-0.9% -$4.61M 0.68% 24
2015
Q1
$487M Buy
4,964,426
+183,315
+4% +$18.6M 0.56% 30
2014
Q4
$451M Buy
4,781,111
+1,370,041
+40% +$142M 0.51% 34
2014
Q3
$363M Buy
3,411,070
+1,190,662
+54% +$117M 0.41% 43
2014
Q2
$184M Buy
2,220,408
+1,004,044
+83% +$78.2M 0.21% 94
2014
Q1
$86.2M Buy
1,216,364
+163,520
+16% +$12.8M 0.11% 163
2013
Q4
$79.1M Buy
1,052,844
+37,192
+4% +$2.59M 0.11% 163
2013
Q3
$63.9M Sell
1,015,652
-55,744
-5% -$3.33M 0.1% 171
2013
Q2
$54.9M Buy
+1,071,396
New +$55.8M 0.1% 174

Other funds holding GILD

Bank of Montreal's GILD Position: Q1 2026 in Review

Bank of Montreal increased its Gilead Sciences (GILD) stake by 2.3% in Q1 2026, buying an estimated $11.3M and bringing the position to 3,549,224 shares worth $495M. The position accounts for 0.18% of the portfolio, ranked #97.

Bank of Montreal first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $576M in Q2 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Bank of Montreal held 3,549,224 shares of Gilead Sciences worth $495M as of Q1 2026.
  • Bank of Montreal bought 80,430 Gilead Sciences shares in Q1 2026, an estimated $11.3M.
  • Gilead Sciences made up 0.18% of Bank of Montreal's portfolio in Q1 2026, its #97 holding.
  • Bank of Montreal first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Gilead Sciences position peaked at $576M in Q2 2015.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.